Peters D K, Martin A, Weinstein A, Cameron J S, Barratt T M, Ogg C S, Lachmann P J
Clin Exp Immunol. 1972 Jul;11(3):311-20.
Detailed studies of the complement system were carried out in fifteen patients with membranoproliferative glomerulonephritis. The findings of reduced levels of C3 and C7 and of circulating breakdown products of C3 in fresh plasma suggested complement activation. Low C3 levels were associated with the presence of a serum factor (the C3 nephritic factor C3NeF) which was capable of breaking down C3 in normal serum . Metabolic studies using radioactive iodine labelled C3 showed no evidence of accelerated breakdown of parenterally administered C3 suggesting that hypocomplementaemia is either maintained by diminished C3 synthesis or that accelerated catabolism is occurring in a pool that does not freely exchange with parenterally given C3. The C3 nephritic factor has so far only been identified in patients with membranoproliferative nephritis and is therefore of major diagnostic significance in patients with glomerular disease.
对15例膜增生性肾小球肾炎患者的补体系统进行了详细研究。新鲜血浆中C3和C7水平降低以及C3循环裂解产物的发现提示补体激活。低C3水平与一种血清因子(C3肾炎因子C3NeF)的存在有关,该因子能够分解正常血清中的C3。使用放射性碘标记的C3进行的代谢研究未显示肠外给予的C3有加速分解的证据,这表明低补体血症要么是由C3合成减少维持的,要么是在一个与肠外给予的C3不能自由交换的池中发生了加速分解代谢。迄今为止,C3肾炎因子仅在膜增生性肾炎患者中被鉴定出来,因此对肾小球疾病患者具有重要的诊断意义。